Evidence map›Paper›PMID 40933909›Full record

ReviewCureus2025

Disparities in Heart Failure Epidemiology, Diagnosis, Management, and Outcomes.

Amy R Yan, Pratyaksh K Srivastava, Darko Vucicevic, Manyoo A Agarwal, Boback Ziaeian, Gregg C Fonarow, Ali Nsair, Negeen Shahandeh

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amy R YanCardiology, The Bishop's School, La Jolla, USA.
Pratyaksh K SrivastavaCardiology, Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles, Los Angeles, USA.
Darko VucicevicCardiology, Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles, Los Angeles, USA.
Manyoo A AgarwalCardiology, Cardio-Oncology Program, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.
Boback ZiaeianCardiology, Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles, Los Angeles, USA.
Gregg C FonarowCardiology, Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles, Los Angeles, USA.
Ali NsairCardiology, Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles, Los Angeles, USA.
Negeen ShahandehCardiology, Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) disproportionately impacts minority groups in the United States. Among minorities living with HF, disparities exist in treatment, access to advanced therapies such as durable left ventricular assist devices and heart transplantation, and outcomes. Reasons for observed disparities range from the prevalence of traditional cardiovascular risk factors to social determinants of health, including housing, access to healthcare, and socioeconomic status. Clinical practice guidelines frequently are unable to address these observed disparities, and clinical trials often underrepresent minority populations. Custom programs tailored toward addressing disparities in HF care are needed to help improve outcomes in minority populations.

Indexed as

healthcare disparitiesheart failure hospitalizationheart failure outcomesmanagement of heart failureracial disparitysex disparity

Identifiers

PMID40933909
PMCPMC12419552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.